Patent: 7,510,873
Summary for Patent: 7,510,873
| Title: | Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same |
| Abstract: | Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described. |
| Inventor(s): | Mistry; Sanjay (Bedminster, NJ), Kihm; Anthony J. (Princeton, NJ), Harris; Ian Ross (Belle Mead, NJ), Harmon; Alexander M. (Clinton, NJ), Messina; Darin J. (Somerville, NJ), Yi; Chin-Feng (Hillsborough, NJ), Gosiewska; Anna (Skillman, NJ) |
| Assignee: | Ethicon, Incorporated (Somerville, NJ) |
| Application Number: | 10/877,012 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,510,873
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | May 5, 2004 | ⤷ Start Trial | 2024-06-25 |
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | December 2, 2004 | ⤷ Start Trial | 2024-06-25 |
| Amphastar Pharmaceuticals, Inc. | AMPHADASE | hyaluronidase | Injection | 021665 | October 26, 2004 | ⤷ Start Trial | 2024-06-25 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | ⤷ Start Trial | 2024-06-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
